Physician

Vanessa Chao Lichon, M.D.

According to 2025 Medicare claims, Vanessa Lichon, M.D. (NPI: 1528294097) practices micrographic dermatologic surgery in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is DUPAGE MEDICAL GROUP LTD (NPI: 1801833983; TIN: 36-2657618) and primary practice location at 60148-7132. Lichon is affiliated with the DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (ACO ID: D0265), participating under the REACH model.

Lichon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 959 traditional Medicare patients, billed 3,687 HCPCS/CPT codes, and received $758,799 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 2,253 prescription claims across 1,262 beneficiaries totaling $61,168 in drug costs, led by Gentamicin Sulfate (Gentamicin Sulfate). Open Payments data shows 3 records totaling $67. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $841,617 and ending at $758,799. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $47,650 and ending at $61,168. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	940	3,725	$841,617
2016	1,082	4,379	$942,112
2017	672	2,804	$509,302
2018	868	4,936	$755,597
2019	972	6,459	$960,603
2020	914	4,998	$887,117
2021	941	5,248	$952,627
2022	863	3,694	$781,934
2023	949	4,288	$849,057
2024	959	3,687	$758,799

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	475	833	$47,650
2016	580	973	$21,573
2017	379	591	$15,476
2018	570	873	$15,057
2019	726	1,303	$21,716
2020	823	1,347	$18,571
2021	991	1,653	$143,556
2022	1,018	1,697	$32,038
2023	1,131	1,922	$23,890
2024	1,262	2,253	$61,168

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	599	725	$517
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	239	319	$337
12052	Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm	202	222	$132
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	176	199	$68
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	218	253	$42

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gentamicin Sulfate	Gentamicin Sulfate	196	4,077	$6,546
Doxycycline Hyclate	Doxycycline Hyclate	603	4,492	$3,200
Mupirocin	Mupirocin	311	5,509	$2,141
Cephalexin	Cephalexin	534	3,602	$1,802
Fluorouracil	Fluorouracil	28	824	$1,753

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$67	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vanessa Chao Lichon, M.D.?

Tedicare shows public-source Medicare data for Vanessa Chao Lichon, M.D. (NPI 1528294097), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vanessa Chao Lichon, M.D. have ACO affiliation data?

Vanessa Chao Lichon, M.D. is shown with ACO affiliation data for DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (REACH, ACO ID D0265).

What billing organization is linked to Vanessa Chao Lichon, M.D.?

Vanessa Chao Lichon, M.D. is linked to DUPAGE MEDICAL GROUP LTD (billing NPI 1801833983) in the available physician profile data.

Does Vanessa Chao Lichon, M.D. have Open Payments data?

Vanessa Chao Lichon, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.